Learn More
Invitrogen™ AVPR1A Recombinant Rabbit Monoclonal Antibody (7H23L17)
Description
This antibody is predicted to react with Monkey, Rabbit, Cat. Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | AVPR1A |
| Applications | Immunohistochemistry, Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | 7H23L17 |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.4 |
| Gene | AVPR1A |
| Gene Accession No. | P30560, P37288 |
| Gene Alias | antidiuretic hormone receptor 1A; arginine vasopressin receptor 1A; arginine vasopressin receptor V1a; AVPR; AVPR V1a; AVPR1; Avpr1a; SCCL vasopressin subtype 1a receptor; V1a; V1a arginine vasopressin receptor; V1a receptor; V1a vasopressin receptor; V1aR; V1-vascular vasopressin receptor AVPR1A; Vascular/hepatic-type arginine vasopressin receptor; vasopressin V1a receptor; Vasopressin V1aR |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.